IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Inflammatory Breast Cancer
Hoffmann-La Rochemonoclonal_antibodyPhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 95/ 100
Competitive context
25 Active assets in the Inflammatory Breast Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Northwestern University | Phase 3 | BBB |
Carboplatin Northwestern University | Phase 3 | BBB |
TRASTUZUMAB Hoffmann-La Roche | Phase 3 | BBB |
Docetaxel Association Tunisienne de lutte Contre le Cancer | Phase 3 | BBB |
Inno-206 M.D. Anderson Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →